Cellectar Biosciences (CLRB) and Evestia Clinical have entered into an agreement whereby Evestia will provide Cellectar with full CRO services for their upcoming Phase 1b study evaluating CLR 125 for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback